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Abstract 1 
Introduction: Exercise acutely alters markers of bone resorption and formation. As fracture 2 
risk is increased in patients with type 1 diabetes, understanding if exercise-induced bone 3 
turnover is affected within this population is prudent. We assessed bone turnover responses to 4 
acute exercise in individuals with long-duration type 1 diabetes and matched controls.  5 
Research Design and Methods: Type 1 diabetes participants (n=15; age: 38.7±13.3, HbA1c: 6 
60.5±6.7mmol/mol; diabetes duration: 19.3±11.4years) and age-, fitness-, BMI-matched 7 
controls (n=15) completed 45 minutes of incline walking (60%VO2peak). Blood samples were 8 
collected at baseline and immediately, 30, and 60 minutes post-exercise. Markers of bone 9 
resorption (type-1 cross-linked ꞵ-C-telopeptide [ꞵ-CTx]) and formation (procollagen type-1 N-10 
terminal propeptide [P1NP]), parathyroid hormone (PTH), phosphate, and calcium (albumin-11 
adjusted and ionised) were measured. Data (mean±SD) were analysed by a mixed-model 12 
ANOVA. 13 
Results: Baseline concentrations of P1NP and ꞵ-CTx were comparable between type 1 14 
diabetes participants and controls. P1NP did not change with exercise (p=0.20) but ꞵ-CTx 15 
decreased (p<0.001) in both groups, but less so in type 1 diabetes participants compared to 16 
controls (-9.2±3.7%; p=0.02). PTH and phosphate increased immediately post-exercise in both 17 
groups; PTH only, was raised at 30 minutes post-exercise, (p<0.001) with no between-group 18 
differences (p>0.39). Type 1 diabetes participants had reduced albumin and ionised calcium at 19 
all sample points (p<0.01).  20 
Conclusions: Following exercise, type 1 diabetes participants displayed similar time course 21 
changes in markers of bone formation, associated metabolites, but an attenuated suppression 22 
in bone resorption. The reduced albumin and ionised calcium may have implications for future 23 
bone health. Further investigation of the interactions between type 1 diabetes, differing 1 
modalities and intensities of exercise, and bone health is warranted. 2 
 3 
What is already known about this subject? 
• Individuals with type 1 diabetes are at increased risk of skeletal fracture and have reduced bone density 
and turnover, while physical activity has been demonstrated to improve bone health in healthy 
populations. 
What are the new findings? 
• This is the first study to investigate the acute effects of exercise upon biochemical markers of bone 
resorption and formation in individuals with type 1 diabetes. 
• Our study demonstrates that exercise has a similar acute time-course effects on bone turnover in 
individuals with type 1 diabetes compared to age-, sex- and fitness matched non-diabetes controls. 
• Individuals with type 1 diabetes may have an attenuated reduction in bone resorption after exercise 
compared to the controls. 
How might these results change the focus of research or clinical practice? 
• As the acute bone turnover response exercise is largely normal, exercise may be a viable strategy to 
reducing the increased incidence of future fractures and osteoporosis in a growing elderly population of 
patients with type 1 diabetes. 
• Research is needed to explore the optimal type, duration, and intensity of exercise to maximise bone 
turnover in adults with long-term type 1 diabetes, and whether this can translate into reduced incidence of 
fractures and osteoporosis. 
Introduction 1 
Osteoporosis and fractures are common complications of type 1 diabetes with a one- to two-2 
fold increased fracture risk at any skeletal site.(1, 2) Long-term type 1 diabetes is associated 3 
with deficits in bone density, structure, microarchitecture, and turnover.(3, 4) Exposure to 4 
hyperglycemia and oxidative stress,(5, 6) elevated sclerostin,(4) insulinopenia and decreased 5 
gastrointestinal hormones, and chronic inflammation are all potential drivers of this.(7) At the 6 
time of clinical manifestation of type 1 diabetes around 80% of β-cell mass is already lost.(8, 7 
9) In parallel, lower levels of bone formation and resorption markers including osteocalcin, 8 
procollagen type 1 propeptides amino-terminal (PINP), and crosslinking telopeptides of type 1 9 
collagen ꞵ-C-terminal (ꞵ-CTx) are observed.(10) In addition to bone remodelling being 10 
impaired in recently diagnosed individuals, a diagnosis before or during puberty and poor 11 
glycemic control are further associated with reduced bone turnover and bone mineral 12 
density.(3, 10, 11) 13 
Human bone is continuously undergoing resorption, its breakdown by osteoclasts releasing 14 
calcium and phosphate into the circulation, and formation, a process by which osteoblasts lay 15 
down new bone material.(12) Osteocytes, the most abundant bone cell phenotype that regulates 16 
bone formation and initiate bone resorption, controls bone remodelling by responding to 17 
mechanical strain.(13) After a certain age, varying between individuals, the rate of bone 18 
resorption starts to exceed the rate of bone formation, resulting in net bone loss.(12) As the 19 
type 1 diabetes population ages, so does the rate of diabetes-induced osteoporotic fractures.(1) 20 
In combination with the increased life expectancy seen during the past century due to 21 
improvements in management and survival in type 1 diabetes,(14, 15) interventions are needed 22 
to reduce the occurrence of osteoporotic fractures in this growing population of older type 1 23 
diabetes individuals.  24 
Regular exercise should be an integral part of modern diabetes management.(16) Structured 1 
training and physical activity have the potential to improve glycemic control, reduce 2 
inflammation, lower the demand for exogenous insulin, and improve quality of life.(16-18) 3 
Exercise training has been shown to increase bone formation and decrease bone resorption in 4 
healthy and disease states,(19) thus exercise interventions may be able to improve bone health 5 
in those with type 1 diabetes. Whilst endurance exercise programs have not appeared to benefit 6 
bone health in diabetic rats,(20, 21) there is limited evidence of the effects of exercise on bone 7 
turnover in humans with type 1 diabetes. Previous studies have demonstrated that a 9 month 8 
weight bearing and 3 month aerobic exercise interventions were successful at increasing bone 9 
mineral density and altering circulating levels of biochemical bone turnover markers in 10 
children and adolescents with type 1 diabetes, respectively.(22, 23) However, little is known 11 
on the acute effects of physical activity on the markers of bone turnover in individuals with 12 
type 1 diabetes.    13 
As over 90% of the organic matrix of bone is type 1 collagen, many of the commonly used 14 
markers of bone turnover relate to its synthesis or degradation.(24) These include P1NP, 15 
cleaved during the synthesis of type 1 collagen and thus a marker of bone formation, and ꞵ-16 
CTx, a product of the degradation of type 1 collagen and thus a marker of bone resorption.(25) 17 
As bone resorption and formation are tightly coupled, high levels of either bone resorption 18 
markers or bone formation markers signify a high bone turnover rate.(25) Single exercise bouts 19 
have been shown to alter circulating concentrations of P1NP and ꞵ-CTx, parathyroid hormone 20 
(PTH), a regulator of bone remodelling, and related metabolites (calcium and phosphate) in 21 
young and old people free-from disease.(26-28) Given the deficits observed in bone turnover 22 
within type 1 diabetes patients, it is important to understand if the bone turnover response to 23 
acute exercise is comparable to those without diabetes, and what clinical factors are driving 24 
any abnormalities.  25 
Studies investigating the bone response to exercise in healthy individuals have mainly been 1 
carried out in fasted conditions, often involving intense exercise.(19, 25, 28-30) As moderate-2 
intensity and duration aerobic exercise is the most commonly advocated physical activity by 3 
the American Diabetes Association (ADA),(16) and a carbohydrate snack prior to exercise is 4 
often required to meet the international consensus advice on pre-exercise blood glucose 5 
concentration to reduce the risk of exercise-induced hypoglycemia,(17) it is unclear how 6 
applicable this research is to the type 1 diabetes population. Additionally, the challenges of 7 
glycemic management, and various comorbidities can make performing intense exercise 8 
unrealistic for individuals with type 1 diabetes.  9 
The aim of the present study was to investigate the bone turnover response to moderate-10 
intensity, continuous physical exercise in people with type 1 diabetes compared to healthy 11 
controls, replicating real world exercise practices of this population.  12 
Methods 13 
Ethical considerations 14 
This single-centre, case-control trial was performed in line with Good Clinical Practice and the 15 
Declaration of Helsinki. Following approval from the NHS HRA North East Tyne & Wear 16 
South Research Ethics Committee, fully informed participants gave written consent before any 17 
trial related activities. The trial was registered at the ISRCTN registry 18 
(http://www.isrctn.com/ISRCTN10346879). 19 
Participants 20 
Eligibility criteria for the type 1 diabetes group comprised age between 18 and 65 years 21 
(inclusive), clinical diagnosis of type 1 diabetes (weight loss, ketotic, hyperglycemic and 22 
insulin initiation at diagnosis) at least three years before enrolment, glycosylated hemoglobin 23 
(HbA1c) < 10.0% (86 mmol/mol), and absence of clinically diagnosed diabetes-related micro- 24 
/ macro-vascular complications (apart from background retinopathy), recent fractures, or 1 
abnormal estimated glomerular filtration rate. A minimum duration of diabetes of three years 2 
was used to allow a clear gap from the approximate 2 year point often referred to as the ‘honey 3 
moon period’.(31) Participants had to have stable Multiple Daily Injection (MDI) or 4 
Continuous Subcutaneous Insulin Infusion (CSII) regimen without changes over the preceding 5 
6 months. The healthy control group was matched for gender, age, cardio-respiratory fitness 6 
(peak oxygen uptake [VO2peak]) and anthropometry. Participants with type 1 diabetes were 7 
recruited from the Newcastle Diabetes Centre by posters and clinicians passing the details of 8 
interested patients to the study team. The healthy control group were recruited from Newcastle 9 
University, using posters and emailing lists. 10 
Screening visit 11 
Participants attended the Newcastle NIHR Clinical Research Facility on two separate 12 
occasions. Firstly, participants attended for a screening visit to determine eligibility, medical 13 
assessment and resting electrocardiogram. Eligible participants then completed a maximal 14 
graded walking to running exercise treadmill test based on the Bruce protocol,(32) as 15 
previously described by our group.(33) Participants with type 1 diabetes had their capillary 16 
blood glucose concentration measured prior to the maximal test. If blood glucose was below 7 17 
mmol/L (126 mg/dL) then 10-30 grams of carbohydrate was orally administered via a glucose 18 
drink.(17, 34) If blood glucose was above 15 mmol/L (270 mg/dl) the test was rescheduled. 19 
Breath-by-breath respiratory parameters (MetaLyzer 3B; Cortex, Leipzig, Germany) and heart 20 
rate (H10; Polar, Kempele, Finland) were continuously recorded throughout the maximal test. 21 
VO2peak was determined by the average oxygen consumption measured over the 30 seconds 22 
prior to test termination. 23 
Trial visits 1 
Participants returned to the laboratory at least one week after their screening visit and following 2 
an overnight fast (from 10 PM). Participants were instructed to maintain their normal basal 3 
insulin regimen, while if they had a hypoglycemic event overnight prior to the study visit, the 4 
visit was rearranged. On arrival at ~8.30am, the non-dominant arm of each participant was 5 
cannulated. One 10 ml EDTA (Becton, Dickinson and Company, New Jersey, USA) and two 6 
serum separation tubes (SSTTM II Advance, Becton, Dickinson and Company, New Jersey, 7 
USA) were collected at all-time points (baseline, immediately post-exercise [0 min post], 30 8 
minutes post and 60 minutes post). An additional 4 ml EDTA vacutainer® was drawn at 9 
baseline for analysis of HbA1c. The EDTA and one SSTTM vacutainer were centrifuged for 10 
10 minutes at 1500g at 4˚C; serum and plasma were aliquoted and stored at -80˚C in the Faculty 11 
of Medical Sciences Biobank facility.  12 
Participants ate a carbohydrate snack (Belvita Soft Bakes Chocolate Chip, Mondelēz 13 
International, USA), providing 204 kcal including 31g carbohydrate, immediately after 14 
baseline blood tests and remained rested for 30 minutes before starting the trial protocol. After 15 
assessment for a safe blood glucose level 7 mmol/L [126 mg/dL] to 12 mmol/L [216 mg/dL] 16 
(17) participants completed 45 minutes of steady state incline walking on a treadmill at an 17 
exercise intensity set at 60% of VO2peak. If blood glucose dropped below 7 mmol/L during the 18 
exercise, the type 1 diabetes participants were given an additional 10g of carbohydrate. 19 
Individuals’ breath-by-breath respiratory parameters (MetaLyzer 3B; Cortex, Leipzig, 20 
Germany) and heart rates (H10; Polar, Kempele, Finland) were continuously recorded 21 
throughout the exercise session. Immediately after cessation of exercise, a further blood sample 22 
was collected, before participants were seated. Further venous samples were collected at 30 23 
minutes and 60 minutes post-exercise, after which the cannula was removed and the participant 24 
discharged from the laboratory if glucose concentration >3.9 mmol/L (70 mg/dL).  25 
Blood sample analysis 1 
Ionised calcium concentrations and HbA1c were analysed by routine hospital clinical 2 
biochemistry (Royal Vitoria Infirmary, Newcastle upon Tyne). EDTA plasma concentrations 3 
of ꞵ-CTx, PINP, and PTH were measured using electrochemiluminescence immunoassay 4 
(ECLIA) on a Cobas e601 analyser (Roche Diagnostics, Germany), with inter-assay coefficient 5 
of variation (CV) ≤3% within the analytical range 0.2-1.5 µg/L, 20-600 µg/L and 0.127‑530 6 
pmol/L, respectively. Serum total calcium, phosphate, and albumin were measured using 7 
standard spectrophotometric methods performed on the Roche Cobas c501 analyser, with inter-8 
assay CVs ≤2% within the analytical range of 0.05-5.00 mmol/L, 0.10-6.46 mmol/L and 10-70 9 
g/L, respectively. Serum albumin values were used to calculate the albumin-adjusted calcium 10 
(ACa) using the equation ACa=(0.8×[Albumin-4])+[Total calcium]. The analyses took place 11 
at the Bioanalytical Facility (University of East Anglia, UK).  12 
Statistical analysis 13 
Participants’ characteristics were tabulated as frequencies and percentages (%) for qualitative 14 
variables and means±standard deviations (SD) for quantitative variables. A mixed model 15 
(Time*Group) repeated measures ANOVA with Tukey post-hoc analysis was performed for 16 
absolute values and baseline adjusted percentage change values a) to assess the effect of 17 
moderate-intensity physical exercise on bone turnover markers over time; b) to compare the 18 
overall effect of exercise on bone turnover markers in people with type 1 diabetes and healthy 19 
controls; and c) to examine the difference in the effect of exercise on bone turnover markers 20 
over time between people with type 1 diabetes and healthy individuals. Resting counts were 21 
assessed by independent t-test. Data were assessed for normality and outliers by Shapiro-Wilk 22 
test and boxplots, with skewed data transformed. Relationships were assessed by Pearson’s or 23 
Spearman’s correlation. 24 
Sample size was estimated from available data;(35, 36) in order to detect a difference of at least 1 
5% in the changes in ꞵ-CTx, P1NP, and PTH with exercise between groups a sample size of 2 
15 (excluding dropout) per group was needed to test the null hypothesis that the population 3 
means are equal with a probability of 0.8. The type 1 error associated with this test is 0.05. 4 
Data are presented as means±standard deviation (SD). A P-value <0.05 was considered 5 
statistically significant.  6 
Results                                                                                                                       7 
Fifteen people with type 1 diabetes (age: 38.7±13.3, diabetes duration: 19.3±11.4 years, 8 
method of control: MDI n=6 and CSII n=9) and age-, fitness-, anthropometric- and gender-9 
matched controls were included in this case-control study (Table 1). No participant reported 10 
having a dietary pattern or restrictions that would suggest an abnormal habitual dietary calcium 11 
intake. All participants completed the protocol without any adverse events or missed samples. 12 
The two groups exercised at a matched intensity of their VO2peak (type 1 diabetes: 60.4±4.4 % 13 
vs. control: 60.8±5.1 %, p=0.734).  14 
Table 1: Characteristics of participants at baseline. Data are presented as mean ± SD. 15 
Variable 
Type 1 diabetes 
(n=15) 
Control 
(n=15) 
P-Value 
Age (years) 38.7 ± 13.3 41.6 ± 12.4 0.546 
Gender, n (%)    
Female 7 (46.7) 7 (46.7) 
-- 
Male 8 (53.3) 8 (53.3) 
Ethnicity, n (%) 
White British 
Indian 
African 
 
14 (93.3) 
1 (6.7) 
0 (0) 
 
14 (93.3) 
0 (0) 
1 (6.7) 
 
BMI (kg/m2)  24.2 ± 2.1 23.9 ± 3.2 0.775 
VO2peak (ml/kg/min) 39.1 ± 9.3 44.7 ± 11.6 0.153 
HbA1c (mmol/mol) 60.5 ± 6.7  34.0 ± 2.2 <0.001 
HbA1c Range (mmol/mol) 53 to 74 30 to 39  
BMI: body mass index; HbA1c: glycated hemoglobin; VO2peak: body weight relativized peak 
oxygen uptake. Independent sample t-tests were performed to compare quantitative variables 
between groups.  
 1 
The absolute data are presented in  2 
Figure 1, with percentage change from baseline plotted in  3 
 4 
 5 
 6 
 7 
 8 
Figure 2. The P values for main effects of time, group, and group*time interaction are included 9 
with each parameter within Figures 1 and 2. Baseline concentrations for all markers are 10 
presented in Table 2.  11 
***INSERT FIGURES 1 AND 2 HERE*** 12 
There were main effects of time for ꞵ-CTx, PTH, albumin, phosphate, and calcium (Figure 1).  13 
There were group effects for albumin, and ionized calcium with controls having higher 14 
concentrations of both measures at rest and at all time points, when compared with type 1 15 
diabetes (Figure 1.D + 1.H, Table 2.). There were time*condition effects for ꞵ-CTx only, with 16 
the control group only having a reduced concentration at 60 minutes compared to baseline 17 
(Figure 1.A). When expressed as a percentage change from baseline, there were time*group 18 
interactions for ꞵ-CTx, with reduction in concentrations of 16±12 % versus 25±8 % in the type 19 
1 diabetes group and controls, respectively (p=0.018; Figure 2.A). 20 
HbA1c was inversely related to albumin (r=-0.657, p< 0.001) in the fasted state. VO2peak was 1 
related to fasting levels of ꞵ-CTx (r=0.478, p=0.008) and P1NP (r= 0.417, p=0.022). Duration 2 
of type 1 diabetes was inversely associated with fasted concentrations of albumin (r= -0.636, 3 
p<0.001) and ꞵ-CTx (r=-0.535, p=0.045). Within the type 1 diabetes group, neither HbA1c, 4 
BMI nor VO2peak predicted any percentage change with exercise of the measured variables 5 
(p>0.05). An older age and longer duration of diabetes was associated with a greater decrease 6 
in albumin (r=-0.757, p=0.001; r=-0.635, p=0.011), calcium (r=-0.764, p=0.001; r=-0.574, 7 
p=0.025) and adjusted calcium (r=-0.748, p=0.001; r=-0.555, p=0.032) at 30 minutes post 8 
exercise, respectively.   9 
Table 2: Resting concentrations of biochemical markers of bone turnover. Data are 10 
presented as mean ± SD. 11 
 12 
 13 
Discussion  14 
The aim of the present study was to assess whether the bone turnover response to acute exercise 15 
in type 1 diabetes differs compared to that in matched controls free from diabetes. Previous 16 
Variable 
Type 1 diabetes 
(n=15) 
Control 
(n=15) 
P-Value 
ꞵ-CTx (μg/L) 0.32 ± 0.17 0.40 ± 0.16 0.174 
P1NP (μg/L) 44.58 ± 22.06 54.40 ± 25.57 0.235 
PTH (pmol/L) 2.37 ± 1.03 2.89 ± 0.90 0.149 
Albumin (g/L) 39.44 ± 2.03 43.11 ± 2.47 <0.001 
Phosphate (mmol/L) 1.05 ± 0.19 1.02 ± 0.18 0.675 
Calcium (mmol/L) 2.26 ± 0.08 2.27 ± 0.8 0.652 
Adjusted Calcium (mg/dL) 2.27 ± 0.08 2.24 ± 0.07 0.394 
Ionised Calcium (mmol.L) 1.16 ± 0.04 1.20 ± 0.01 0.011 
Independent sample t-tests were performed to compare quantitative variables between 
groups.  
research has largely studied the bone turnover response to acute exercise in healthy 1 
individuals.(19, 28-30, 35) This was the first study, to the best of our knowledge, to assess this 2 
acute response in humans with type 1 diabetes, with previous research having been carried out 3 
in diabetic rat models (20, 21) or exploring exercise training over several months in children 4 
or adolescents with type 1 diabetes.(22, 23) The key findings were: 1) baseline P1NP 5 
concentrations were comparable between groups and unaffected by moderate-intensity 6 
exercise, 2) baseline ꞵ-CTx concentrations were also comparable between groups and fell with 7 
exercise (more so in controls), 3) PTH and phosphate levels both rose with exercise, with no 8 
difference between groups, and 4) those with type 1 diabetes had overall lower levels of 9 
albumin and ionised calcium. Our data provide a clinically relevant insight into the interaction.  10 
In the present study moderate-intensity exercise caused no change in P1NP, a fall in ꞵ-CTx, 11 
and a rise in PTH in both participants with type 1 diabetes and controls. While there was no 12 
statistically significant differences in resting concentration of P1NP and ꞵ-CTx in the current 13 
study (Table 2.), the baseline ꞵ-CTx concentration of 0.8 μg/L lower in type 1 diabetes group 14 
compared to the controls is similar to the significantly reduced ꞵ-CTx levels (−0.10 μg/L, 95% 15 
confidence intervals −0.18 to −0.01 μg/L) seen in a recent meta-analysis.(4) While a lack of 16 
studies have investigated P1NP in type 1 diabetes specifically, the resting concentration in this 17 
study (-9.82 μg/L in the type 1 diabetes group in comparison to the controls) is reduced a similar 18 
amount as individuals with type 2 diabetes compared to controls.(4)  19 
P1NP 20 
Moderate intensity exercise training has previously been demonstrated to alter resting P1NP 21 
concentration. Indeed, Adami et al. (37) found that P1NP increased after an exercise program 22 
of a month’s duration in pre-menopausal women, which was associated with increased bone 23 
mineral density. In comparison, Maggio et al. (22) did not find a significant change in P1NP in 24 
either children with or without type 1 diabetes competing 9 months of two 90-min plyometric 1 
exercise sessions per week compared to non-exercising controls. This is despite the type 1 2 
diabetes group having significantly lower resting concentration. In comparison, Elhabashy et 3 
al. (23) demonstrated that P1NP significantly increased by 40% after 3 months of 3 60-min 4 
aerobic exercise per week in adolescent with type 1 diabetes. However, without a control group 5 
it is unclear if this was a normal response. While both studies found increases in bone mineral 6 
density, differences in biochemical markers of bone turnover are likely due to differing 7 
populations, the frequency and type of exercise used. The acute P1NP response to exercise is 8 
less clear with Rantalainen et al. (28) finding a non-significant increase in P1NP 24 hours, but 9 
not immediately, after a jumping exercise carried out to exhaustion. Hammond et al. (38) and 10 
Townsend et al. (35) found an immediate increase in P1NP post exercise in both fasted and fed 11 
states before a subsequent decline below baseline by an hour post 8 × 5 min running at 85% 12 
VO2peak HIT or running at 75% VO2max till exhaustion. It is possible that our protocol was not 13 
strenuous enough to induce an increase in P1NP, or that we did not take measurements over a 14 
sufficient time period to detect such a rise. Never the less, Scott et al. (30) reported an acute 15 
increase in P1NP levels when healthy males ran at 55%, 65%, and 75% of VO2max, but there 16 
was no effect of exercise intensity on P1NP response. It is possible the amount of mechanical 17 
strain, rather than the exercise intensity, is key to inducing P1NP secretion.(25) It would thus 18 
be interesting to repeat our study using a running protocol.  19 
ꞵ-CTx 20 
The fall in ꞵ-CTx observed implies that there was a lower rate of bone resorption at the end of 21 
exercise. Scott et al. (30) also found that ꞵ-CTx fell in their study both during and for three 22 
hours after treadmill running at 55% and 65% of VO2max. Other studies have however observed 23 
ꞵ-CTx to increase with acute exercise or be unaffected. Indeed, Guillemant et al. (29) found 24 
elevated ꞵ-CTx levels in male athletes after 60 minutes of cycling at 80% VO2max. The acute 25 
response of ꞵ-CTx to exercise may depend on the exercise type, duration, and intensity as well 1 
as the individual’s age, sex, habitual loading of bones.(19, 39, 40) Importantly, prior 2 
consumption of calcium or carbohydrate, as administered in this study, appears to result in 3 
greater suppression of ꞵ-CTx during and after exercise compared to fasting conditions.(29, 35, 4 
38) Additionally, ꞵ-CTx is influenced by the circadian rhythm, peaking at 5:30am, with the 5 
nadir at 1:30pm.(41) After 9 months of exercise training, Maggio et al. (20) found both children 6 
with and without type 1 diabetes had reduced levels of ꞵ-CTx, however the reduction was less 7 
than both the type 1 diabetes and control groups who did not go through the exercise 8 
intervention.  In the present study baseline ꞵ-CTx levels were (not significantly) lower, and 9 
when adjusted for baseline the percentage decrease with exercise in those with type 1 diabetes 10 
was less than the controls. This suggests that bone in type 1 diabetes may have a lower basal 11 
rate of turnover and remodels less in response to a bout of fed moderate intensity exercise. 12 
Further investigation is needed to understand if the acute difference seen in ꞵ-CTx around 13 
exercise are clinically relevant in the long term.  14 
PTH 15 
The exercise-induced rise in PTH that we observed was in keeping with previous work (26) 16 
and was likely due mainly to a fall in ionised calcium.(36)  As with P1NP and ꞵ-CTx, there 17 
may be an exercise intensity threshold for PTH secretion in endurance exercise.(26) Whilst 18 
high basal levels of PTH have a catabolic effect, intermittent PTH secretion, such as that 19 
observed here, has an anabolic effect on bone,(13) stimulating proliferation and inhibiting 20 
apoptosis in osteoblasts.(26) It is difficult to prove without a longer-term study, but tempting 21 
to suggest, that our exercise protocol had a positive net effect on bone turnover in both the 22 
healthy controls and the type 1 diabetes group, even if the ꞵ-CTx resorption response may be 23 
slightly attenuated in the latter. 24 
Bone turnover associated metabolites 1 
In the current study, those with type 1 diabetes had lower absolute levels of albumin compared 2 
to controls. A longer duration of type 1 diabetes and poorer glycemic control were both also 3 
associated with lower fasted levels of albumin. This is unsurprising, as hepatic albumin 4 
production is stimulated by insulin and is therefore decreased in type 1 diabetes.(42) We also 5 
found lower levels of ionised calcium in participants with type 1 diabetes compared with 6 
controls. This has been reported previously, as a result of reduced intestinal absorption and 7 
increased urinary excretion of calcium, as well as the dysregulated PTH secretion observed in 8 
type 1 diabetes.(43) Whilst still within normal ranges, the lower levels of albumin and ionised 9 
calcium in the type 1 diabetes group compared to the age-, gender-, anthropometry- and 10 
cardiorespiratory fitness-matched controls may be an indicator of future clinical implications 11 
such as oedema formation, neuromuscular irritability, and cardiac complications of 12 
hyoocalcemia. In the present study the response of calcium, ionised calcium, adjusted calcium, 13 
and albumin to exercise was in line with previous studies (26, 44) and the same in both groups: 14 
falling 30 minutes post-exercise and returning to baseline by 60 minutes post. The response of 15 
phosphate to exercise was also comparable between groups: increasing immediately after and 16 
returning to baseline by 30 minutes post-exercise. This reflects previous studies carried out in 17 
healthy individuals.(36, 44) As inorganic phosphate is a major component of bone mineral, its 18 
post-exercise rise may be evidence of bone resorption having occurred during the protocol.(36) 19 
In type 1 diabetes calcium, albumin, and phosphate homeostasis is deranged,(42, 43) and yet 20 
we found that moderate-intensity exercise could still induce appropriate changes in their 21 
profiles. Bone in type 1 diabetes is thus seemingly still responsive to acute exercise.  22 
Type 1 diabetes and bone health 23 
As healthcare continues to improve, people with type 1 diabetes are living longer.(14, 15) As 1 
most are diagnosed during their youth / young adulthood,(45) they are exposed for many years 2 
to the effects of hyperglycemia, and do not fully benefit from the anabolic effects of 3 
endogenous insulin on bone during the period of peak acquisition of bone mass.(10) Chronic 4 
hyperglycemia results in the formation of advanced glycation end products, which suppress 5 
bone formation, increases bone brittleness and impairs fracture healing.(46) Long-term 6 
hyperglycemia also compromises bone vasculature, resulting in decreased bone 7 
remodelling.(1) This results is poor bone mineral density and quality, and a high rate of 8 
osteoporotic fractures in an ageing type 1 diabetes population.(1, 6) This ultimately may leads 9 
to increased morbidity and mortality.(3) Exercise can improve glycemic control (17) and 10 
sensitivity to exogenous insulin,(18) and was shown to reduce the risk of falls and fractures in 11 
the elderly through a Cochrane review,(47) a complication that individuals with type 1 diabetes 12 
are highly vulnerable to.(48) Yet exercise rates are lower in those with type 1 diabetes, with 13 
reasons including fear of hypoglycaemia, uncertainty about how to control blood sugars around 14 
exercise, and diabetes complications.(17) Our data show that those with type 1 diabetes still 15 
benefit from the acute effects of exercise on bone turnover. This further underlines the benefits 16 
of exercise in type 1 diabetes and that it may be a viable strategy to reducing the osteoporotic 17 
fracture rate in older individuals with type 1 diabetes.   18 
Strengths, limitations and future work 19 
Comparing our exercising type 1 diabetes group to a control group who rested, or having 20 
participants perform the protocol in a fasted state would have provided useful further data. 21 
However, we were most interested in studying the bone turnover response in type 1 diabetes to 22 
exercise under real world conditions: moderate intensity, moderate duration exercise as 23 
recommended by the ADA,(16) whilst following international guidelines for glycemic 24 
management around exercise.(17) We believe this makes the research more generalizable and 25 
is a strength.  A limitation of the current study was blood samples not being taken during 1 
exercise or beyond one hour afterwards, which would have given us information on any mid-2 
exercise or delayed post-exercise response of bone turnover markers. Additionally, measuring 3 
bone mineral density at rest would have been interesting to explore if this was associated with 4 
the bone turnover response to acute exercise. As baseline samples were fasted, changes in bone 5 
turnover markers likely have been impacted by the consumption of the carbohydrate snack.(40) 6 
Whilst our type 1 diabetes group had a range of ages and HbA1c levels, our study was not 7 
designed to explore the influence of age and HbA1c on the bone turnover response to exercise. 8 
Future studies should explore how individuals with differing HbA1c respond to exercise in 9 
order to translate this research to the wider type 1 diabetes population. As individuals with type 10 
1 diabetes are at increased risk of fractures due to trabecular and cortical bone density 11 
defects,(6) understanding if exercise improves bone quality at sites most at risk of fractures 12 
would be beneficial.  Further understanding how clinical factors, such as age and sex 13 
differences, influences the bone turnover response to exercise would also be beneficial. Indeed, 14 
as C-peptide infusion improved bone quality in a type 1 diabetic rat model (49) and endogenous 15 
C-peptide secretion partially predicts post exercise glycaemic control, residual ꞵ-cell function 16 
may influence bone turnover in individuals with type 1 diabetes.(33)  17 
Conclusion 18 
We present novel data on the response of bone turnover markers to acute exercise in type 1 19 
diabetes. Whilst bone remodelling is dysregulated in type 1 diabetes, we found fed moderate-20 
intensity walking to have a similarly positive impact on biochemical markers of bone turnover 21 
in those with type 1 diabetes compared to controls, evidenced by the rise in PTH and the fall 22 
in ꞵ-CTx. Studies carried out in healthy individuals suggest that exercise protocols that 23 
maximise mechanical strain on the bone may be superior for bone health,(13, 50) and that 24 
commencing exercise at a young age is important.(25) Further research should aim to decipher 25 
the optimal exercise type, duration, and intensity to maximise bone turnover in the long-term 1 
in type 1 diabetes. This will be key to reducing the incidence of fractures and osteoporosis in 2 
this patient group, and ultimately improving morbidity and mortality.  3 
 4 
 5 
 6 
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Figure 1: Absolute change of ꞵ-CTx (A), P1NP (B), PTH (C), albumin (D), phosphate (E), 2 
calcium (F), adjusted calcium (G) and ionised calcium (H) in response to a single bout of 3 
moderate-intensity exercise in those with type 1 diabetes and healthy controls. ꞵ-CTx: 4 
crosslinking telopeptides of type 1 collagen C-terminal; P1NP: procollagen type 1 propeptides 5 
amino-terminal; PTH: parathyroid hormone. Blood samples were collected 30 minutes before 6 
exercise (baseline), and immediately (0 min post), 30, and 60 minutes after cessation of 7 
exercise.  8 
#[ - Significant main effect of group differences,   △ – Significant main effect of time difference 9 
from baseline, *| - Significant group differences at time point,  △ (green triangle) - Significant 10 
time difference from baseline in the type 1 diabetes group, △ (blue triangle) - Significant time 11 
difference from baseline in the control group 12 
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Figure 2: Percentage change from baseline of ꞵ-CTx (A), P1NP (B), PTH (C), albumin 2 
(D), phosphate (E), calcium (F), adjusted calcium (G) and ionised calcium (H) in response 3 
to a single bout of moderate-intensity exercise in those with type 1 diabetes and healthy 4 
controls. ꞵ-CTx: crosslinking telopeptides of type 1 collagen C-terminal; P1NP: procollagen 5 
type 1 propeptides amino-terminal; PTH: parathyroid hormone. Blood samples were collected 6 
30 minutes before exercise (baseline), and immediately (0 min post), 30, and 60 minutes after 7 
cessation of exercise. 8 
#[ - Significant main effect of group differences,   △ – Significant main effect of time difference 9 
from baseline, *| - Significant group differences at time point,  △ (green triangle) - Significant 10 
time difference from baseline in the type 1 diabetes group, △ (blue triangle) - Significant time 11 
difference from baseline in the control group 12 
 13 
 14 
 15 
 16 
 17 
 18 
